SCHEMBL904680

SCHEMBL904680

Cc1cc(Br)ccc1S(=O)(=O)NCc1ccc2c(ccn2C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
ALDH1A1 P00352 7/20 0.45
MEN1 O00255 7/20 0.45
KMT2A Q03164 7/20 0.45
MAPT P10636 6/20 0.45
RECQL P46063 5/20 0.45
POLB P06746 2/20 0.45
GAA P10253 1/20 0.45
S100A4 P26447 1/20 0.45
THRB P10828 6/20 0.44
BAZ2B Q9UIF8 1/20 0.42
CHRNA7 P36544 3/20 0.42
PKM P14618 1/20 0.41
LMNA P02545 1/20 0.41
NPC1 O15118 1/20 0.40
NR2F2 P24468 1/20 0.40
NOD2 Q9HC29 1/20 0.40
BRD4 O60885 1/20 0.40
BRD1 O95696 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL904735 0.82 CA1 (0.46) CA1CA2ALDH1A1MEN1KMT2A
SCHEMBL904772 0.82 CHRNA7 (0.50) ALDH1A1MEN1KMT2AMAPTRECQL
SCHEMBL904700 0.77 CA1 (0.42) CA1CA2ALDH1A1MEN1KMT2A
SCHEMBL120177 0.75 LMNA (0.66) CA1CA2KMT2AMAPTPOLB
SCHEMBL904791 0.72 CHRNA7 (0.47) ALDH1A1MAPTCHRNA7LMNANPSR1
SCHEMBL904599 0.70 LMNA (0.41) ALDH1A1MEN1KMT2AMAPTRECQL
SCHEMBL904754 0.70 CA1 (0.42) CA1CA2ALDH1A1MEN1KMT2A
SCHEMBL16098346 0.70 CA1 (0.66) CA1CA2ALDH1A1GAALMNA
SCHEMBL904798 0.70 POLB (0.57) ALDH1A1MEN1KMT2AMAPTRECQL
SCHEMBL856111 0.69 PRKCI (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829026-B2 Sulfamoyl benzoic acid heterobicyclic derivatives as TRPM8 antagonists RAQUALIA PHARMA INC. (JP) 2014-09-09 US disclosed
US-20130210858-A1 SULFAMOYL BENZOIC ACID HETEROBICYCLIC DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2013-08-15 US disclosed
WO-2012042915-A1 SULFAMOYL BENZOIC ACID HETEROBICYCLIC DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210858-A1 SULFAMOYL BENZOIC ACID HETEROBICYCLIC DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM6, TRPM5 CA1 868/4885CA2 197/4885ALDH1A1 2692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.